Therapeutic uses of bactericidal/permeability increasing protein products
AssigneeXoma Corporation
InventorsRoger G. Little, II, Helene Gazzano-Santoro, James B. Parent
Life of this patent
Estimating the term…
Abstract
The present invention provides therapeutic methods for treatment of conditions including the neutralization of the anti-coagulant activity of heparin, inhibition of angiogenesis, tumor and endothelial cell proliferation, and treatment of chronic inflammatory diseases by administration of bactericidal/permeability-increasing (BPI) protein products.
Claims2
A method for neutralizing the anti-coagulant effect of heparin comprising administering to a subject suffering from heparin-mediated lengthening of clotting time an effective amount of a heparin binding bactericidal/permeability-increasing (BPI) protein product.
Dependencies are inferred from the claim text.